InvestorsHub Logo
Followers 76
Posts 3281
Boards Moderated 0
Alias Born 03/16/2014

Re: None

Thursday, 09/26/2019 9:07:03 AM

Thursday, September 26, 2019 9:07:03 AM

Post# of 693492
PROS :

Krystyn Power : 3 resections , 30% of the tumour removed , Given 2 weeks to live , got DCVAX -L anyway and still alive at 5 years

`An amazing number of progression free long term survivors , literally impossible in historical SoC `

DC VAX Blended OS vs Optune , 23.1months v 19.3m cheaper and far superior QoL

Several Ways to BLA : 4 Regulatory Authorities , Stat Sig PFS , Stat Sig OS

Information Arm : 40% of patients lived > 3 years , 20% > 5 years & 12% > 7 years

`The majority of 3 years survivors were progression free ` 19th March 2019 LL

Ph3 Trial August 2019 = 4 years from Surgery

`Appears to be consistent with the blinded interim data from the trial` Keyoumars Ashkan

`The patients were NOT healthier than the norm ` Linda Liau

CONS : All poor management related but I dont care

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News